𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hexamethylmelamine—A new drug with activity in solid tumors

✍ Scribed by Ronald H. Blum; Robert B. Livingston; Stephen K. Carter

Book ID
114012768
Publisher
Elsevier Science
Year
1973
Weight
473 KB
Volume
9
Category
Article
ISSN
0014-2964

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B-859-35, a new drug with anti-tumor act
B-859-35, a new drug with anti-tumor activity reverses multi-drug resistance
✍ Johann Hofmann; Florian Ueberall; Alexander Egle And; Hans Grunicke 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 569 KB

It has previously been shown that 6-859-35 ((-)-3-methyl-5-3-(4,4-diphenyl-I -piperidinyl)-propyl-I ,4-dihydro-2,6-d i m e t h y 1-44 3-n i tro p h en y I)-p y rid i ne-3,5-d i car boxylate-hydrochloride) exerts a selective carcinostatic effect on some tumors. In order to evaluate whether the anti-c

BRAF, a target in melanoma : Implication
BRAF, a target in melanoma : Implications for solid tumor drug development
✍ Keith T. Flaherty; Grant McArthur 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

## Abstract The successful translation of therapies targeting signal‐transduction pathways that are activated by oncogenes has provided a model for molecularly targeted therapy, and the identification of mutations in v‐raf murine sarcoma viral oncogene homolog B1 (__BRAF__), a serine/threonine kina